MENADIONE

MENADIONE was reported 139 times

MENADIONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERSONALITY DISORDER OF CHILDHOOD 1 0.0769
1 CARDIO-RESPIRATORY ARREST NEONATAL 2 0.0256
2 SUBDURAL HAEMATOMA EVACUATION 1 0.0133
3 CLEFT UVULA 1 0.0127
4 CARCINOID HEART DISEASE 1 0.0110
5 CORNEAL CYST 1 0.0103
6 OSTEOCHONDRITIS 1 0.0093
7 TOE WALKING 1 0.0085
8 STICKY SKIN 3 0.0075
9 RHONCHI 8 0.0058
10 BILE ACIDS INCREASED 1 0.0056
11 RUBBER SENSITIVITY 8 0.0052
12 NIPPLE DISORDER 3 0.0048
13 RENAL FAILURE NEONATAL 1 0.0045
14 CHOROIDAL EFFUSION 3 0.0037
15 HYPERADRENOCORTICISM 1 0.0036
16 GENITOURINARY TRACT INFECTION 1 0.0035
17 HAIR INJURY 1 0.0034
18 HEPATIC ISCHAEMIA 1 0.0032
19 GASTRIC PH DECREASED 3 0.0029
20 GAIT SPASTIC 1 0.0029
21 LORDOSIS 1 0.0028
22 CAPILLARY DISORDER 1 0.0026
23 ANKYLOGLOSSIA CONGENITAL 1 0.0025
24 CRANIOTOMY 1 0.0024
25 CONGENITAL FOOT MALFORMATION 1 0.0022
26 NEEDLE FATIGUE 1 0.0022
27 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
28 HYPERSPLENISM 1 0.0020
29 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
30 PULMONARY FUNCTION TEST DECREASED 8 0.0018
31 EYE INFECTION BACTERIAL 1 0.0018
32 MEDIASTINITIS 1 0.0017
33 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
34 BRADYCARDIA NEONATAL 2 0.0016
35 RENAL SURGERY 1 0.0015
36 POST PROCEDURAL SEPSIS 1 0.0015
37 NEURODEVELOPMENTAL DISORDER 1 0.0015
38 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 8 0.0015
39 STOMA CREATION 1 0.0014
40 PCO2 INCREASED 1 0.0014
41 BUNION 1 0.0014
42 NODAL RHYTHM 2 0.0014
43 AXILLARY PAIN 2 0.0013
44 LIMB ASYMMETRY 1 0.0013
45 DAYDREAMING 2 0.0013
46 NEONATAL DISORDER 2 0.0013
47 HAEMOPERITONEUM 1 0.0012
48 SYNDACTYLY 1 0.0012
49 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
50 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
51 DEVICE RELATED THROMBOSIS 1 0.0010
52 ARTERIAL HAEMORRHAGE 1 0.0009
53 PHOBIA 1 0.0009
54 FOETAL ANTICONVULSANT SYNDROME 1 0.0008
55 SPUTUM DISCOLOURED 8 0.0008
56 HAEMATOMA MUSCLE 1 0.0008
57 SUBCUTANEOUS HAEMATOMA 1 0.0008
58 HYPOVITAMINOSIS 1 0.0008
59 CLUSTER HEADACHE 1 0.0007
60 CYSTIC FIBROSIS 4 0.0007
61 DEATH NEONATAL 1 0.0007
62 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
63 PULMONARY VALVE INCOMPETENCE 1 0.0007
64 KNEE DEFORMITY 1 0.0007
65 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
66 URINE ABNORMALITY 3 0.0007
67 STOMA SITE HAEMORRHAGE 1 0.0006
68 PORTAL HYPERTENSION 2 0.0006
69 LIMB DEFORMITY 1 0.0006
70 RESPIRATORY DISORDER NEONATAL 1 0.0006
71 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
72 DENTAL IMPLANTATION 1 0.0006
73 EDUCATIONAL PROBLEM 1 0.0006
74 SEIZURE LIKE PHENOMENA 1 0.0006
75 DEAFNESS BILATERAL 1 0.0006
76 BLOOD PH DECREASED 1 0.0006
77 SENSITIVITY TO WEATHER CHANGE 3 0.0006
78 MONOPARESIS 1 0.0006
79 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
80 NASAL OBSTRUCTION 1 0.0005
81 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
82 VENOUS THROMBOSIS LIMB 1 0.0005
83 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
84 READING DISORDER 1 0.0004
85 BILIRUBIN CONJUGATED INCREASED 1 0.0004
86 DYSMORPHISM 1 0.0004
87 MYOPIA 1 0.0004
88 SUFFOCATION FEELING 1 0.0004
89 PAROSMIA 3 0.0004
90 CANCER PAIN 1 0.0004
91 INCREASED BRONCHIAL SECRETION 1 0.0004
92 VENTRICULAR DYSFUNCTION 1 0.0004
93 NASAL DISORDER 1 0.0004
94 TRICHORRHEXIS 1 0.0004
95 THERAPEUTIC RESPONSE DELAYED 1 0.0004
96 PRODUCTIVE COUGH 17 0.0004
97 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
98 OESOPHAGEAL STENOSIS 1 0.0004
99 HYPERTONIC BLADDER 1 0.0003
100 STRABISMUS 1 0.0003
101 TOOTH DISCOLOURATION 1 0.0003
102 INFUSION SITE REACTION 1 0.0003
103 DEVELOPMENTAL DELAY 3 0.0003
104 CRANIOCEREBRAL INJURY 1 0.0003
105 KERATITIS 1 0.0003
106 PORTAL VEIN THROMBOSIS 1 0.0003
107 DIZZINESS POSTURAL 3 0.0003
108 PLASMA CELL MYELOMA RECURRENT 1 0.0003
109 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
110 DEAFNESS NEUROSENSORY 1 0.0003
111 INFUSION SITE HAEMORRHAGE 1 0.0003
112 OTITIS MEDIA 1 0.0003
113 CARDIAC FAILURE ACUTE 2 0.0003
114 WOUND COMPLICATION 1 0.0003
115 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
116 JAUNDICE CHOLESTATIC 1 0.0003
117 HAEMORRHAGIC DIATHESIS 1 0.0003
118 LIVER TRANSPLANT 1 0.0003
119 SPONDYLITIS 1 0.0003
120 GASTROINTESTINAL PAIN 3 0.0003
121 WOUND HAEMORRHAGE 1 0.0003
122 PROTEIN TOTAL DECREASED 1 0.0003
123 FACE INJURY 1 0.0003
124 COMMUNICATION DISORDER 1 0.0003
125 ENURESIS 1 0.0002
126 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
127 POOR PERIPHERAL CIRCULATION 1 0.0002
128 ANURIA 2 0.0002
129 VASCULAR DEVICE INFECTION 1 0.0002
130 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
131 EAR DISORDER 1 0.0002
132 NEPHROLITHIASIS 10 0.0002
133 POST PROCEDURAL COMPLICATION 4 0.0002
134 FOOT OPERATION 1 0.0002
135 HYPERNATRAEMIA 1 0.0002
136 CORONARY ARTERIAL STENT INSERTION 1 0.0002
137 CACHEXIA 1 0.0002
138 FAILURE TO THRIVE 1 0.0002
139 TONSILLITIS 1 0.0002
140 SCIATICA 3 0.0002
141 ANORECTAL DISCOMFORT 1 0.0002
142 LEARNING DISABILITY 1 0.0002
143 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
144 FOOD POISONING 1 0.0002
145 OVERWEIGHT 1 0.0002
146 BEHAVIOUR DISORDER 1 0.0002
147 HYPERKERATOSIS 1 0.0002
148 FOOT DEFORMITY 2 0.0002
149 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
150 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
151 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
152 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
153 PLEURISY 1 0.0002
154 GALLBLADDER DISORDER 3 0.0002
155 ODYNOPHAGIA 1 0.0002
156 MUSCLE RIGIDITY 2 0.0002
157 PROTHROMBIN TIME PROLONGED 1 0.0002
158 FOETAL GROWTH RESTRICTION 1 0.0002
159 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
160 INFUSION SITE EXTRAVASATION 1 0.0002
161 PRE-EXISTING CONDITION IMPROVED 1 0.0002
162 INFUSION SITE SWELLING 1 0.0002
163 BLEPHAROSPASM 1 0.0002
164 INCREASED APPETITE 3 0.0002
165 INFLAMMATION 8 0.0002
166 SOMNAMBULISM 1 0.0002
167 DYSGRAPHIA 1 0.0002
168 IMPAIRED GASTRIC EMPTYING 2 0.0001
169 THERMAL BURN 1 0.0001
170 PRODUCT SUPPLY ISSUE 1 0.0001
171 NEUTROPENIC SEPSIS 1 0.0001
172 RASH PUSTULAR 1 0.0001
173 WHEEZING 8 0.0001
174 SHOCK 3 0.0001
175 APHTHOUS ULCER 1 0.0001
176 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
177 PULMONARY HAEMORRHAGE 1 0.0001
178 TORSADE DE POINTES 1 0.0001
179 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
180 INFECTION 18 0.0001
181 COAGULOPATHY 2 0.0001
182 PSEUDOMONAS INFECTION 1 0.0001
183 CARDIAC MURMUR 1 0.0001
184 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
185 TUMOUR LYSIS SYNDROME 1 0.0001
186 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
187 HAEMOLYTIC ANAEMIA 1 0.0001
188 OROPHARYNGEAL DISCOMFORT 1 0.0001
189 HIDRADENITIS 1 0.0001
190 HEPATIC CIRRHOSIS 2 0.0001
191 INTENTIONAL DOSE OMISSION 3 0.0001
192 EYE INFLAMMATION 1 0.0001
193 ACUTE RESPIRATORY FAILURE 2 0.0001
194 HYPOGLYCAEMIA 5 0.0001
195 RENAL TUBULAR NECROSIS 1 0.0001
196 HEPATOMEGALY 1 0.0001
197 HYPOTONIA 1 0.0001
198 BRAIN INJURY 1 0.0001
199 DRUG LEVEL DECREASED 1 0.0001
200 EUPHORIC MOOD 1 0.0001
201 ASTHMA 11 0.0001
202 LIMB DISCOMFORT 3 0.0001
203 INCONTINENCE 1 0.0001
204 SUDDEN DEATH 1 0.0001
205 CYSTITIS 3 0.0001
206 HEREDITARY ANGIOEDEMA 1 0.0001
207 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
208 PULMONARY THROMBOSIS 1 0.0001
209 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
210 WOUND INFECTION 1 0.0001
211 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
212 TRANSAMINASES INCREASED 2 0.0001
213 NERVE INJURY 1 0.0001
214 URINARY RETENTION 3 0.0001
215 FISTULA 1 0.0001
216 STATUS EPILEPTICUS 1 0.0001
217 CHEST DISCOMFORT 9 0.0001
218 MICTURITION URGENCY 1 0.0001
219 SPLENOMEGALY 1 0.0001
220 BLOOD IRON DECREASED 1 0.0001
221 ATAXIA 1 0.0001
222 NOCTURIA 1 0.0001
223 DYSURIA 3 0.0001
224 ENCEPHALOPATHY 2 0.0001
225 MUSCLE SPASTICITY 1 0.0001
226 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
227 HEPATIC CYTOLYSIS 1 0.0001
228 HEPATITIS 2 0.0001
229 DEAFNESS 2 0.0001
230 ORAL CANDIDIASIS 1 0.0001
231 DISTURBANCE IN ATTENTION 4 0.0001
232 UVEITIS 1 0.0001
233 TACHYPNOEA 1 0.0001
234 DRUG TOXICITY 1 0.0001
235 AKATHISIA 1 0.0001
236 ACUTE HEPATIC FAILURE 1 0.0001
237 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
238 MASS 1 0.0001
239 CARPAL TUNNEL SYNDROME 1 0.0001
240 OXYGEN SATURATION DECREASED 4 0.0001
241 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
242 PAIN IN JAW 2 0.0001
243 SUBDURAL HAEMATOMA 1 0.0001
244 SEPTIC SHOCK 3 0.0001
245 MENTAL DISORDER 3 0.0001
246 ASCITES 2 0.0001
247 ABDOMINAL DISTENSION 7 0.0001
248 HEPATIC FAILURE 2 0.0001
249 ABSCESS 1 0.0001
250 LACTIC ACIDOSIS 2 0.0001
251 VISUAL ACUITY REDUCED 2 0.0001
252 BLOOD PRESSURE DECREASED 4 0.0001
253 CANDIDA INFECTION 1 0.0001
254 MULTI-ORGAN FAILURE 1 0.0001
255 DEVICE DEFECTIVE 1 0.0001
256 NERVOUSNESS 3 0.0001
257 SPEECH DISORDER 3 0.0001
258 EOSINOPHILIA 1 0.0001
259 DEPRESSED MOOD 3 0.0001
260 BRADYCARDIA 3 0.0001
261 GOUT 1 0.0001
262 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
263 OSTEOMYELITIS 1 0.0001
264 HEPATIC STEATOSIS 1 0.0001
265 BACTERIAL INFECTION 1 0.0001
266 GASTRIC ULCER 1 0.0001
267 HAEMORRHOIDS 1 0.0001
268 CHOKING 1 0.0001
269 SURGERY 3 0.0001
270 KIDNEY INFECTION 1 0.0001
271 SINUS DISORDER 1 0.0001
272 PNEUMONIA 16 0.0000
273 DISCOMFORT 3 0.0000
274 HAEMOGLOBIN DECREASED 5 0.0000
275 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
276 KNEE ARTHROPLASTY 1 0.0000
277 MOUTH ULCERATION 1 0.0000
278 HALLUCINATION, VISUAL 1 0.0000
279 RHINORRHOEA 3 0.0000
280 HEPATOTOXICITY 1 0.0000
281 PANCREATITIS ACUTE 1 0.0000
282 PRODUCT AVAILABILITY ISSUE 1 0.0000
283 MUSCLE TWITCHING 1 0.0000
284 BLOOD CHOLESTEROL INCREASED 2 0.0000
285 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
286 COGNITIVE DISORDER 2 0.0000
287 PRODUCT PRESCRIBING ERROR 1 0.0000
288 BLOOD PRESSURE FLUCTUATION 1 0.0000
289 RESPIRATORY FAILURE 3 0.0000
290 NEURALGIA 1 0.0000
291 LIVER INJURY 1 0.0000
292 DYSPEPSIA 4 0.0000
293 CELLULITIS 2 0.0000
294 HAEMATEMESIS 1 0.0000
295 ERECTILE DYSFUNCTION 1 0.0000
296 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
297 RESPIRATORY TRACT INFECTION 1 0.0000
298 SEDATION 1 0.0000
299 JOINT STIFFNESS 1 0.0000
300 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
301 MEMORY IMPAIRMENT 5 0.0000
302 CARDIAC ARREST 3 0.0000
303 RESPIRATORY DISTRESS 1 0.0000
304 INFLUENZA 4 0.0000
305 SEPSIS 4 0.0000
306 NECK PAIN 2 0.0000
307 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
308 MUSCULAR WEAKNESS 4 0.0000
309 ANGINA PECTORIS 1 0.0000
310 PALPITATIONS 4 0.0000
311 BONE PAIN 2 0.0000
312 CHILLS 4 0.0000
313 ACUTE MYOCARDIAL INFARCTION 1 0.0000
314 TACHYCARDIA 3 0.0000
315 URINARY INCONTINENCE 1 0.0000
316 GASTROINTESTINAL DISORDER 3 0.0000
317 BLOOD POTASSIUM DECREASED 1 0.0000
318 PREMATURE BABY 1 0.0000
319 APHASIA 1 0.0000
320 VERTIGO 2 0.0000
321 NASOPHARYNGITIS 6 0.0000
322 EMOTIONAL DISORDER 1 0.0000
323 RASH 14 0.0000
324 COUGH 9 0.0000
325 METABOLIC ACIDOSIS 1 0.0000
326 WEIGHT INCREASED 7 0.0000
327 MOVEMENT DISORDER 1 0.0000
328 NIGHT SWEATS 1 0.0000
329 IMPAIRED HEALING 1 0.0000
330 FEBRILE NEUTROPENIA 2 0.0000
331 DEHYDRATION 4 0.0000
332 DRY SKIN 4 0.0000
333 TYPE 2 DIABETES MELLITUS 1 0.0000
334 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
335 GASTRIC DISORDER 1 0.0000
336 NIGHTMARE 1 0.0000
337 HYPERKALAEMIA 1 0.0000
338 LYMPHADENOPATHY 1 0.0000
339 CEREBRAL HAEMORRHAGE 1 0.0000
340 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
341 MUSCLE SPASMS 5 0.0000
342 THROMBOCYTOPENIA 3 0.0000
343 DYSARTHRIA 1 0.0000
344 PYREXIA 9 0.0000
345 ALOPECIA 5 0.0000
346 DISORIENTATION 1 0.0000
347 DRUG INTERACTION 4 0.0000
348 WEIGHT DECREASED 7 0.0000
349 ABORTION SPONTANEOUS 1 0.0000
350 THROMBOSIS 2 0.0000
351 TREMOR 4 0.0000
352 POLLAKIURIA 1 0.0000
353 CARDIO-RESPIRATORY ARREST 1 0.0000
354 ROAD TRAFFIC ACCIDENT 1 0.0000
355 RENAL IMPAIRMENT 2 0.0000
356 PAIN IN EXTREMITY 7 0.0000
357 SKIN EXFOLIATION 2 0.0000
358 HYPOACUSIS 1 0.0000
359 LIVER DISORDER 1 0.0000
360 OROPHARYNGEAL PAIN 2 0.0000
361 ABDOMINAL PAIN 5 0.0000
362 PULMONARY EMBOLISM 2 0.0000
363 DISEASE RECURRENCE 1 0.0000
364 MIGRAINE 2 0.0000
365 LUNG DISORDER 1 0.0000
366 HEART RATE INCREASED 2 0.0000
367 DRY EYE 1 0.0000
368 AGGRESSION 1 0.0000
369 HYPOTENSION 4 0.0000
370 SOMNOLENCE 4 0.0000
371 FLUID RETENTION 1 0.0000
372 ARTHRALGIA 8 0.0000
373 HAEMORRHAGE 2 0.0000
374 ECZEMA 1 0.0000
375 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
376 CONSTIPATION 4 0.0000
377 ANAPHYLACTIC REACTION 1 0.0000
378 ARTHROPATHY 1 0.0000
379 ABDOMINAL DISCOMFORT 3 0.0000
380 BLISTER 1 0.0000
381 TOXICITY TO VARIOUS AGENTS 3 0.0000
382 NAUSEA 14 0.0000
383 CONVULSION 1 0.0000
384 DECREASED APPETITE 4 0.0000
385 DYSPHONIA 1 0.0000
386 VOMITING 8 0.0000
387 CATARACT 1 0.0000
388 FATIGUE 13 0.0000
389 FEELING ABNORMAL 4 0.0000
390 STOMATITIS 1 0.0000
391 PLEURAL EFFUSION 1 0.0000
392 VISUAL IMPAIRMENT 2 0.0000
393 EXPOSURE DURING PREGNANCY 1 0.0000
394 DYSPNOEA 9 0.0000
395 GAIT DISTURBANCE 3 0.0000
396 INTENTIONAL OVERDOSE 1 0.0000
397 RENAL FAILURE 2 0.0000
398 INSOMNIA 4 0.0000
399 NEUTROPENIA 2 0.0000
400 HEPATIC ENZYME INCREASED 1 0.0000
401 ABDOMINAL PAIN UPPER 3 0.0000
402 INJECTION SITE REACTION 1 0.0000
403 BURNING SENSATION 1 0.0000
404 SLEEP DISORDER 1 0.0000
405 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
406 EPISTAXIS 1 0.0000
407 HALLUCINATION 1 0.0000
408 CONDITION AGGRAVATED 4 0.0000
409 BLOOD PRESSURE INCREASED 2 0.0000
410 INJECTION SITE BRUISING 1 0.0000
411 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
412 DIARRHOEA 8 0.0000
413 DIZZINESS 6 0.0000
414 BALANCE DISORDER 1 0.0000
415 MUSCULOSKELETAL STIFFNESS 1 0.0000
416 MALAISE 5 0.0000
417 COVID-19 2 0.0000
418 SUICIDAL IDEATION 1 0.0000
419 ADVERSE EVENT 1 0.0000
420 HYPERSENSITIVITY 2 0.0000
421 DYSPHAGIA 1 0.0000
422 NEUROPATHY PERIPHERAL 1 0.0000
423 CONTUSION 1 0.0000
424 OFF LABEL USE 9 0.0000
425 INJECTION SITE PAIN 3 0.0000
426 SINUSITIS 1 0.0000
427 PLATELET COUNT DECREASED 1 0.0000
428 FALL 3 0.0000
429 RHEUMATOID ARTHRITIS 1 0.0000
430 INCORRECT DOSE ADMINISTERED 2 0.0000
431 SEIZURE 1 0.0000
432 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
433 DISEASE PROGRESSION 1 0.0000
434 PAIN 5 0.0000
435 ASTHENIA 3 0.0000
436 LOSS OF CONSCIOUSNESS 1 0.0000
437 PSORIASIS 1 0.0000
438 PRODUCT QUALITY ISSUE 1 0.0000
439 ANXIETY 2 0.0000
440 DRUG INEFFECTIVE 9 0.0000
441 PRODUCT DOSE OMISSION ISSUE 2 0.0000
442 HYPOAESTHESIA 1 0.0000
443 ACUTE KIDNEY INJURY 1 0.0000
444 PARAESTHESIA 1 0.0000
445 CEREBROVASCULAR ACCIDENT 1 0.0000
446 URINARY TRACT INFECTION 1 0.0000
447 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
448 CHEST PAIN 1 0.0000
449 ANAEMIA 1 0.0000
450 PRURITUS 2 0.0000
451 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
452 ERYTHEMA 1 0.0000
453 HEADACHE 3 0.0000
454 HYPERTENSION 1 0.0000
455 DEATH 4 0.0000
456 BACK PAIN 1 0.0000